+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Merck & Co., Inc. - logo

Merck & Co., Inc. is a global healthcare company with operations in more than 140 countries. It offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus and other diseases. The company has collaboration agreements with Adaptimmune Therapeutics plc and Agenus; and a research agreement with Proteros Biostructures. Founded in 1891, it is headquartered in Kenilworth, New Jersey.

Follicular Lymphoma Treatment Market Report 2025 - Product Thumbnail Image

Follicular Lymphoma Treatment Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Mantle Cell Lymphoma Therapeutics Market Report 2025 - Product Thumbnail Image

Mantle Cell Lymphoma Therapeutics Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Non Hodgkin Lymphoma (NHL) Market Report 2025 - Product Thumbnail Image

Non Hodgkin Lymphoma (NHL) Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Cough and Cold Preparations Market Report 2025 - Product Thumbnail Image

Cough and Cold Preparations Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
From
Nasal Drug Delivery Technology Market Report 2025 - Product Thumbnail Image

Nasal Drug Delivery Technology Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
Acute Myeloid Leukemia - Pipeline Insight, 2025 - Product Thumbnail Image

Acute Myeloid Leukemia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Small Cell Lung Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Small Cell Lung Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 100 Pages
  • Global
From
From
Loading Indicator